Pages that link to "Q45855074"

The following pages link to Resistance to HIV protease inhibitors (Q45855074):

Displaying 27 items.

• Solution structure of the mature HIV-1 protease monomer: insight into the tertiary fold and stability of a precursor (Q27641889) (← links)
• Highly conserved glycine 86 and arginine 87 residues contribute differently to the structure and activity of the mature HIV-1 protease (Q27658105) (← links)
• Genetic selection for dissociative inhibitors of designated protein-protein interactions (Q31801167) (← links)
• Salvage treatment against human immunodeficiency virus (Q33730185) (← links)
• Indinavir: a review of its use in the management of HIV infection (Q33826230) (← links)
• Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing (Q33971117) (← links)
• Discovery and clinical development of HIV-1 protease inhibitors (Q34236642) (← links)
• Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients (Q34732022) (← links)
• Accumulation of protease mutations among patients failing second-line antiretroviral therapy and response to salvage therapy in Nigeria. (Q34998736) (← links)
• A protein-based therapeutic for human cytomegalovirus infection (Q35083082) (← links)
• Anti-AIDS agents 73: structure-activity relationship study and asymmetric synthesis of 3-O-monomethylsuccinyl-betulinic acid derivatives (Q36275081) (← links)
• Antiretroviral dynamics determines HIV evolution and predicts therapy outcome (Q36374300) (← links)
• A solution NMR study of the binding kinetics and the internal dynamics of an HIV-1 protease-substrate complex (Q36572105) (← links)
• Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457) (Q37192174) (← links)
• Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach (Q37357408) (← links)
• Basis of selection of first and second line highly active antiretroviral therapy for HIV/AIDS on genetic barrier to resistance: a literature review (Q38263521) (← links)
• Recombinant phenotyping of cytomegalovirus UL54 mutations that emerged during cell passages in the presence of either ganciclovir or foscarnet (Q38282979) (← links)
• Emergence of resistance to protease inhibitor amprenavir in human immunodeficiency virus type 1-infected patients: selection of four alternative viral protease genotypes and influence of viral susceptibility to coadministered reverse transcriptase n (Q39653073) (← links)
• A single-loop recombinant pseudotyped-virus-based assay to detect HIV-1 phenotypic resistance (Q41400528) (← links)
• Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M. (Q41848089) (← links)
• Clinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV-1 infected patients (Q42254682) (← links)
• Using model-system genetics for drug-based target discovery (Q43580950) (← links)
• The impact of the M184V substitution in HIV-1 reverse transcriptase on treatment response (Q43993272) (← links)
• Revisiting monomeric HIV-1 protease. Characterization and redesign for improved properties (Q44240364) (← links)
• Genotyping in HIV drug resistance mutations: epidemiology in 145 patients (Q44260558) (← links)
• Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function (Q73047075) (← links)
• Polymorphisms and drug resistance analysis of HIV-1 isolates from patients on first line antiretroviral therapy (ART) in South-eastern Nigeria (Q91728251) (← links)